Quick Answer
BIOADAPTIVES, INC. reported Total Revenue of $12.7 thousand for fiscal year 2024.
BIOADAPTIVES, INC. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $12.7K -55.6% |
$28.6K +66.3% |
$17.2K -13.1% |
$19.8K +21.1% |
$16.3K +64.4% |
$9.9K |
| Net Income | -$899.2K -26.2% |
-$712.5K +20.4% |
-$895.6K +14.7% |
-$1.05M -23.9% |
-$847.2K -254.6% |
-$238.9K +83.0% |
| Total Assets | $261.9K +151.8% |
$104.0K +178.7% |
$37.3K -74.9% |
$148.6K +688.4% |
$18.8K -22.2% |
$24.2K -78.0% |
| Cash and Equivalents | — | — | $25.4K -69.4% |
$82.9K +1708.1% |
$4.6K -62.7% |
$12.3K -78.1% |
| Stockholders Equity | -$1.46M +11.1% |
-$1.65M -13.4% |
-$1.45M -32.8% |
-$1.09M +20.7% |
-$1.38M -64.2% |
-$839.9K -21.1% |
| Operating Income | -$602.1K -163.0% |
-$228.9K +45.7% |
-$421.9K | — | — | — |
| Gross Profit | $4.0K -62.8% |
$10.8K +51.8% |
$7.1K -29.5% |
$10.1K +65.8% |
$6.1K +24.8% |
$4.9K |
| Shares Outstanding | 8.22M +37.6% |
5.97M -97.6% |
252.55M +397.0% |
50.82M +144.0% |
20.83M +12.1% |
18.58M +2.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $4.6K | — | +43.9% |
| Net Income | September 30, 2025 | -$379.5K | -908.0% | -140.3% |
| Diluted EPS | September 30, 2025 | -$0.04 | — | -300.0% |
| Total Assets | September 30, 2025 | $124.4K | +168.1% | -54.4% |
| Cash and Equivalents | September 30, 2022 | $17.9K | — | -78.4% |
| Stockholders Equity | September 30, 2025 | -$1.47M | +18.8% | -19.0% |
| Operating Income | September 30, 2025 | -$265.7K | -117.9% | +4.8% |
| Gross Profit | September 30, 2025 | $3.9K | — | +262.3% |
| Shares Outstanding | September 30, 2025 | 10.94M | -99.1% | +10.0% |
- BIOADAPTIVES, INC. reported Total Revenue of $12.7 thousand for fiscal year 2024.
- BIOADAPTIVES, INC. showed a decrease of -55.6% in Total Revenue compared to the prior fiscal year.
- BIOADAPTIVES, INC. reported Net Income of -$899.2 thousand for fiscal year 2024.
- BIOADAPTIVES, INC. showed a decrease of -26.2% in Net Income compared to the prior fiscal year.
- BIOADAPTIVES, INC. reported Total Assets of $261.9 thousand for fiscal year 2024.
- BIOADAPTIVES, INC. showed an increase of +151.8% in Total Assets compared to the prior fiscal year.
- BIOADAPTIVES, INC. reported Cash and Equivalents of $25.4 thousand for fiscal year 2022.
- BIOADAPTIVES, INC. showed a decrease of -69.4% in Cash and Equivalents compared to the prior fiscal year.
- BIOADAPTIVES, INC. reported Stockholders Equity of -$1.46 million for fiscal year 2024.
- BIOADAPTIVES, INC. showed an increase of +11.1% in Stockholders Equity compared to the prior fiscal year.
- BIOADAPTIVES, INC. reported Operating Income of -$602.1 thousand for fiscal year 2024.
- BIOADAPTIVES, INC. showed a decrease of -163.0% in Operating Income compared to the prior fiscal year.
- BIOADAPTIVES, INC. reported Gross Profit of $4.0 thousand for fiscal year 2024.
- BIOADAPTIVES, INC. showed a decrease of -62.8% in Gross Profit compared to the prior fiscal year.
- BIOADAPTIVES, INC. reported Shares Outstanding of 8.22 million shares for fiscal year 2024.
- BIOADAPTIVES, INC. showed an increase of +37.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: